Cinryze 500 [iU]/5mL
HUMAN C1-ESTERASE INHIBITOR · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Takeda Pharmaceuticals America, Inc.
Cinryze is a injection, powder, lyophilized, for solution containing human c1-esterase inhibitor at 500 [iU]/5mL, taken intravenous. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Cinryze
- Generic Name
- HUMAN C1-ESTERASE INHIBITOR
- NDC Code (Product)
42227-081- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 500 [iU]/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125267
- Marketing Start
- 12/01/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is Cinryze used for?
Cinryze contains HUMAN C1-ESTERASE INHIBITOR. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Cinryze a controlled substance?
Cinryze is not classified as a controlled substance by the DEA.
What is the generic name for Cinryze?
The generic name for Cinryze is HUMAN C1-ESTERASE INHIBITOR. There are 3 other brand versions of HUMAN C1-ESTERASE INHIBITOR.
What is the NDC code for Cinryze 500 [iU]/5mL?
The NDC (National Drug Code) for Cinryze 500 [iU]/5mL is 42227-081, listed by Takeda Pharmaceuticals America, Inc..